Literature DB >> 17709417

Antibody-mediated protection through cross-reactivity introduces a fungal heresy into immunological dogma.

Arturo Casadevall1, Liise-anne Pirofski.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17709417      PMCID： PMC2168287          DOI： 10.1128/IAI.01001-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


× No keyword cloud information.
  45 in total

Review 1.  The multitude of targets for the immune system and drug therapy in the fungal cell wall.

Authors:  Leonardo Nimrichter; Marcio L Rodrigues; Elaine G Rodrigues; Luiz R Travassos
Journal:  Microbes Infect       Date:  2005-03-17       Impact factor: 2.700

2.  Biochemical characterization of Candida albicans epitopes that can elicit protective and nonprotective antibodies.

Authors:  Y Han; T Kanbe; R Cherniak; J E Cutler
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

3.  Anti-glucuronoxylomannan IgG1 specific antibodies production in Cryptococcus neoformans resistant mice.

Authors:  Claudia Parra; John Mario González; Elizabeth Castañeda; Susana Fiorentino
Journal:  Biomedica       Date:  2005-03       Impact factor: 0.935

4.  Inhibitory effect of human natural yeast killer toxin-like candidacidal antibodies on Pneumocystis carinii.

Authors:  N Séguy; J C Cailliez; P Delcourt; S Conti; D Camus; E Dei-Cas; L Polonelli
Journal:  Mol Med       Date:  1997-08       Impact factor: 6.354

5.  Monoclonal yeast killer toxin-like candidacidal anti-idiotypic antibodies.

Authors:  L Polonelli; N Séguy; S Conti; M Gerloni; D Bertolotti; C Cantelli; W Magliani; J C Cailliez
Journal:  Clin Diagn Lab Immunol       Date:  1997-03

6.  Critical role for IgM in host protection in experimental filarial infection.

Authors:  Bhargavi Rajan; Thirumalai Ramalingam; Thiruchandurai V Rajan
Journal:  J Immunol       Date:  2005-08-01       Impact factor: 5.422

7.  A vaccine and monoclonal antibodies that enhance mouse resistance to Candida albicans vaginal infection.

Authors:  Y Han; R P Morrison; J E Cutler
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

8.  A human IgM monoclonal antibody prolongs survival of mice with lethal cryptococcosis.

Authors:  R Fleuridor; Z Zhong; L Pirofski
Journal:  J Infect Dis       Date:  1998-10       Impact factor: 5.226

9.  Human natural yeast killer toxin-like candidacidal antibodies.

Authors:  L Polonelli; F De Bernadis; S Conti; M Boccanera; W Magliani; M Gerloni; C Cantelli; A Cassone
Journal:  J Immunol       Date:  1996-03-01       Impact factor: 5.422

10.  A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection.

Authors:  M Boes; A P Prodeus; T Schmidt; M C Carroll; J Chen
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307
View more
  22 in total

1.  Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis.

Authors:  Hong Xin; Jim E Cutler
Journal:  Clin Vaccine Immunol       Date:  2011-08-10

2.  Identification and characterization of Cryptococcus neoformans protein fractions that induce protective immune responses.

Authors:  Ashok K Chaturvedi; Susan T Weintraub; Jose L Lopez-Ribot; Floyd L Wormley
Journal:  Proteomics       Date:  2013-12       Impact factor: 3.984

3.  Detection of antibodies against Paracoccidioides brasiliensis melanin in in vitro and in vivo studies during infection.

Authors:  Martha E Urán; Joshua D Nosanchuk; Angela Restrepo; Andrew J Hamilton; Beatriz L Gómez; Luz E Cano
Journal:  Clin Vaccine Immunol       Date:  2011-08-03

Review 4.  Innate host defenses against Cryptococcus neoformans.

Authors:  Camaron Hole; Floyd L Wormley
Journal:  J Microbiol       Date:  2016-02-27       Impact factor: 3.422

5.  A histoplasma capsulatum-specific IgG1 isotype monoclonal antibody, H1C, to a 70-kilodalton cell surface protein is not protective in murine histoplasmosis.

Authors:  Livia Cristina Liporagi Lopes; Allan J Guimarães; Mariana Duarte de Cerqueira; Beatriz L Gómez; Joshua D Nosanchuk
Journal:  Clin Vaccine Immunol       Date:  2010-05-19

6.  Antibodies generated against Streptococci protect in a mouse model of disseminated aspergillosis.

Authors:  Rebekah E Wharton; Emily K Stefanov; R Glenn King; John F Kearney
Journal:  J Immunol       Date:  2015-03-27       Impact factor: 5.422

7.  Effects of immune suppression in murine models of disseminated Candida glabrata and Candida tropicalis infection and utility of a synthetic peptide vaccine.

Authors:  Hong Xin
Journal:  Med Mycol       Date:  2019-08-01       Impact factor: 4.076

8.  The monoclonal antibody against the major diagnostic antigen of Paracoccidioides brasiliensis mediates immune protection in infected BALB/c mice challenged intratracheally with the fungus.

Authors:  R Buissa-Filho; R Puccia; A F Marques; F A Pinto; J E Muñoz; J D Nosanchuk; L R Travassos; C P Taborda
Journal:  Infect Immun       Date:  2008-05-05       Impact factor: 3.441

9.  Universal vaccines: shifting to one for many.

Authors:  Antonio Cassone; Rino Rappuoli
Journal:  MBio       Date:  2010-05-18       Impact factor: 7.867

10.  A proteomic-based approach for the identification of immunodominant Cryptococcus neoformans proteins.

Authors:  Mattie Young; Sandra Macias; Derek Thomas; Floyd L Wormley
Journal:  Proteomics       Date:  2009-05       Impact factor: 3.984
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.